Does Medicare Cover Ozempic?
Coverage depends entirely on why it's prescribed — here's how Medicare Part D treats Ozempic for diabetes versus weight loss, and what changes in 2026.
Yes, if you have type 2 diabetes. Medicare Part D covers Ozempic (semaglutide) when it's prescribed for its FDA-approved use — treating type 2 diabetes, and reducing cardiovascular risk in people who have both diabetes and heart disease. Part D does not cover Ozempic when it's prescribed solely for weight loss, because federal law excludes weight-loss drugs from Part D formularies. Ozempic is also not part of the new 2026 Medicare GLP-1 Bridge program, which covers different, weight-loss-labeled drugs instead.
Ozempic has become one of the most talked-about prescriptions in the country, and a lot of that conversation blurs together two very different questions: does Medicare cover the drug, and does Medicare cover weight loss. For Ozempic specifically, the answer hinges on the diagnosis code your doctor submits, not on the drug itself. Get the distinction right and you can avoid a denied claim or a surprise bill at the pharmacy counter.
Why the FDA-approved use matters so much
Ozempic's active ingredient is semaglutide, and the FDA has approved it specifically to treat type 2 diabetes, along with a newer approved use for lowering the risk of heart attack, stroke, and cardiovascular death in adults who have both type 2 diabetes and known heart disease. Weight loss is a common side effect of the drug, and some doctors prescribe it off-label for that purpose — but "off-label for weight loss" and "approved for diabetes" are treated completely differently by Medicare.
That's because of a long-standing federal rule: prescription drugs used for weight loss have historically been excluded from Medicare Part D coverage entirely, going back to the program's earliest formulary rules. Part D plans build their formularies around what's legally allowed, so a plan simply cannot cover Ozempic — or any GLP-1 drug — when the record shows it's being used for weight loss rather than an approved medical condition.
What Original Medicare and Part D actually pay for
Original Medicare (Parts A and B) doesn't cover self-administered prescription drugs like Ozempic at all — that's what Part D prescription drug plans exist for, whether as a standalone plan or bundled into a Medicare Advantage plan (MA-PD). If you have type 2 diabetes and a Part D plan that includes Ozempic on its formulary, here's what to expect:
Formulary placement
Ozempic typically sits on a higher, non-preferred brand-name tier, which usually means a higher copay or coinsurance than generic diabetes drugs.
Prior authorization
Many plans require your doctor to confirm the type 2 diabetes diagnosis before approving the claim, and some require step therapy — trying other diabetes medications first.
Deductible and donut hole
Ozempic's list price is high enough that it can push you through your plan's deductible and into the coverage gap phase faster than lower-cost medications.
Plan-to-plan variation
Not every Part D plan covers Ozempic, and copays for the same diagnosis can vary substantially between plans — it's worth comparing formularies during open enrollment.
Ozempic and the new Medicare GLP-1 Bridge program
Starting July 1, 2026, CMS is running a temporary demonstration called the Medicare GLP-1 Bridge, which lets eligible Part D and MA-PD members access certain GLP-1 medications for weight loss at a flat $50 copay per 30-day supply, through December 31, 2027. It's a significant shift — but it does not include Ozempic. The Bridge program currently covers Wegovy (injection and tablet formulations), the Zepbound KwikPen, and Foundayo, all of which carry an FDA-approved weight-loss or weight-management indication. Ozempic and Mounjaro, the diabetes-labeled versions of semaglutide and tirzepatide, are excluded from the Bridge because they're diabetes drugs, not weight-loss drugs, under their FDA labeling.
In other words: if your goal is Medicare-subsidized weight loss and your doctor is willing to prescribe an FDA-approved weight-management drug, Wegovy under the Bridge program is the relevant option to ask about — not Ozempic. If you already take Ozempic for diabetes, the Bridge program doesn't change your coverage at all; you continue under your plan's standard Part D diabetes benefit.
How to check your specific plan
Because coverage depends on your individual formulary, prior authorization rules, and diagnosis, there's no substitute for checking your own plan directly. Log into your Part D or Medicare Advantage plan's member portal and search the formulary for "semaglutide" or "Ozempic," or call the member services number on your plan card and ask three things: is Ozempic on the formulary, what tier is it on, and does it require prior authorization or step therapy. Your prescriber's office can also submit a prior authorization request on your behalf if one is required.
If cost is a barrier even with coverage, ask your pharmacist or plan about manufacturer savings programs, and check whether you qualify for Extra Help, the federal program that lowers Part D premiums, deductibles, and copays for people with limited income and resources.
Frequently Asked Questions
Does Medicare cover Ozempic for weight loss?
Generally no. Federal law has long excluded drugs used for weight loss from Medicare Part D coverage. Ozempic is only FDA-approved for type 2 diabetes (and cardiovascular risk reduction in people with diabetes and heart disease), so a Part D plan can only cover it under that approved use, not as an off-label weight-loss prescription.
Is Ozempic covered under the new Medicare GLP-1 Bridge program?
No. The Medicare GLP-1 Bridge, a temporary CMS demonstration starting July 1, 2026, covers Wegovy, the Zepbound KwikPen, and Foundayo for weight loss at a $50 monthly copay. Ozempic is not on that list because it's approved as a diabetes drug, not a weight-loss drug — it continues to be covered only through standard Part D diabetes coverage.
What's the difference between Ozempic and Wegovy?
Both contain the same active ingredient, semaglutide, made by the same manufacturer, but they're FDA-approved for different uses. Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management. Medicare treats them differently because it follows the FDA-approved indication on the label, not the active ingredient.
Will my Part D plan cover Ozempic automatically if I have diabetes?
Not automatically. Your plan must include Ozempic on its formulary, and many plans require prior authorization or step therapy showing you've tried other diabetes medications first. Coverage and your copay tier vary by plan, so check your plan's formulary or call your plan directly.
What if my doctor prescribes Ozempic off-label for weight loss?
If the prescription and diagnosis code on file show a use other than type 2 diabetes, your Part D plan can legally deny the claim under the federal weight-loss drug exclusion, and you'd likely pay the full cash price out of pocket.
This article is for general educational purposes and reflects Medicare rules as of August 2026. It is not medical or insurance advice. Coverage depends on your individual diagnosis, prescription, and plan — confirm specifics with your doctor and your Medicare Part D or Medicare Advantage plan.